Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
01/1993
01/21/1993CA2111564A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity
01/20/1993EP0524110A2 Method of culturing Bupleurum Falcatum L.
01/20/1993EP0523949A1 Production of antibodies
01/20/1993EP0523948A2 Method for improving the cancer cell-killing activity of lymphocytes
01/20/1993EP0523056A1 Neutralizing and/or adcc mediating monoclonal hiv antibody
01/20/1993EP0379511B1 Polypeptides with laminin activity
01/20/1993CN1068144A Culture of gene converting plant for resisting cucumber mosaic virus
01/19/1993US5180820 Nucleic acid sequence code
01/19/1993US5180806 Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods
01/19/1993US5180676 Suspension of cells in a liquid fluorocarbon having dissolved oxygen in a culture medium
01/19/1993US5180675 Recombinant fowlpox virus
01/19/1993US5180666 Bioactivation to form metabolite, cytochrome P450, human cells
01/19/1993CA1312839C Generation of neural precursor cell lines
01/13/1993EP0522880A2 Genetic sequences encoding flavonoid pathway enzymes and uses therefor
01/13/1993EP0522868A1 A human endothelin receptor
01/13/1993EP0522530A2 trkC Protein
01/13/1993EP0522482A2 Coccidiosis vaccines
01/13/1993EP0522169A1 Antihuman stromelysin monoclonal antibody and diagnosis of rheumatoid arthritis by enzyme immunoassay
01/13/1993EP0522159A1 Antibody to pituitary adenylate cyclase activating peptide-pacap, hybridoma and assay for pacap
01/13/1993EP0522091A1 Multiple sclerosis t-cell receptor
01/13/1993EP0522086A1 DNA SEQUENCE ENCODING GALACTOPROTEIN b3.
01/13/1993EP0522054A1 Insect retinoid receptor compositions and methods
01/13/1993EP0521915A1 Plant promoter
01/13/1993EP0521910A1 Plant promoter
01/13/1993EP0521909A1 Fetal cell recovery method
01/13/1993EP0521903A1 Human olfactory neuron cultures
01/13/1993EP0521873A1 Anticoagulant proteins
01/13/1993CA2073588A1 Coccidiosis vaccines
01/12/1993US5179078 Method of suppressing tumor formation in vivo
01/12/1993US5179019 Therapeutic murine monoclonal antibody
01/12/1993US5179018 Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
01/12/1993US5178859 Monoclonal antibodies for binding an antigen of Borrelia and epitopes
01/12/1993CA1312568C Method for the aeration, without exit gases, of fermentation media
01/12/1993CA1312476C Method for regulating plant growth
01/09/1993CA2073378A1 Trkc protein
01/07/1993WO1993000441A1 Hormone-secreting cells maintained in long-term culture
01/07/1993WO1993000433A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors
01/07/1993WO1993000432A1 Bmp-9 compositions
01/07/1993WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof
01/07/1993WO1993000424A1 Process for extracting enhanced amounts of plant secondary metabolites with limited loss of plant viability
01/07/1993WO1993000423A1 Iron chelate culture medium additive
01/07/1993WO1993000349A1 Totipotent hematopoietic stem cell receptors and their ligands
01/07/1993WO1993000111A1 Monoclonal antibody to lymphocyte-associated cell surface protein
01/07/1993WO1993000052A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
01/07/1993WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
01/07/1993WO1993000049A1 Osteogenic factor
01/07/1993EP0521842A2 Tumor antigen specific antibody
01/07/1993EP0521674A1 In vitro maturation of denuded bovine oocytes
01/07/1993EP0521586A1 FSH and other recombinant hormones
01/07/1993EP0521435A2 Method to promote the production of secondary metabolites in plant cell cultures
01/07/1993EP0521427A1 Method for identifying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus
01/07/1993EP0484440A4 Efficient directional genetic cloning system
01/07/1993CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof
01/07/1993CA2112492A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors
01/07/1993CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
01/07/1993CA2112375A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
01/07/1993CA2112112A1 Hormone-secreting cells maintained in long-term culture
01/07/1993CA2111984A1 Iron chelate culture medium additive
01/07/1993CA2093790A1 Osteogenic factor
01/06/1993CA2073085A1 Method for identifying non-essential genes of the human cytomegalovirus genome and for screening inhibitors of human cytomegalovirus
01/05/1993WO1993001277A1 Process for culturing t precursor cell line
01/05/1993US5177197 Isolated nucleotide sequence expressing human transforming growth factor-β1-binding protein
01/05/1993US5177193 In vivo half-life, genetic engineering
01/05/1993US5177016 Monoclonal antibody recognizing anthracycline glycoside specific epitope and hybridoma secerning the antibody
01/05/1993CA1312298C Modifying cell metabolism via extra-cellular nucleases
01/02/1993CA2072475A1 In vitro maturation of denuded bovine oocytes
12/1992
12/30/1992EP0578631A4 Cell separation invention.
12/30/1992EP0520748A1 Storage of materials
12/30/1992EP0520604A2 Monoclonal antibody against pentacyclic oleanan-type triterpene and use thereof
12/30/1992EP0520499A1 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
12/30/1992EP0520436A2 Monoclonal antibody, method of production thereof and use thereof
12/30/1992EP0520158A1 Truncated forms of the hepatocyte growth factor (HGF) receptor
12/30/1992EP0520026A1 Megakaryocytic in vitro cell line
12/30/1992EP0188529B1 Electrolyte solutions and in vitro use thereof
12/29/1992WO1993000439A1 In vivo delivery of active factors by co-cultured cell implants
12/29/1992WO1993000063A1 Capsule extrusion systems
12/29/1992US5175103 Preparation of pure cultures of post-mitotic human neurons
12/29/1992US5175092 Polymeric microporous cell growth substrate coated with supporting material and growth factors specific for cell type
12/29/1992US5175004 Propagatable, new combinant cells for cellular replacement therapy
12/29/1992CA2090118A1 Capsule extrusion systems
12/29/1992CA2072412A1 Monoclonal antibody, method of production thereof and use thereof
12/29/1992CA1312030C Method to increase antibody titer
12/29/1992CA1312028C Expression vectors containing the heat shock regulatory dna sequences from a heat shock protein 83 (hsp83) gene and inducible expression by use of the vectors
12/29/1992CA1312027C Methods and compositions for expression of competent eukaryotic gene products
12/29/1992CA1312025C Monoclonal antibodies and antigen for human non-small cell lung carcinomaand certain other human carcinomas
12/24/1992DE4120303A1 Cell poration and fusion avoiding need for cell transfer - using special cell culture insert with porous membrane at base, through which metabolite exchange can take place
12/24/1992DE4120213A1 Monoclonal antibodies against TNF-BP I - used for immunoassays to detect TNF-BP I in diagnosis of bacterial infection septic shock, graft versus host disease and cerebral malaria
12/24/1992DE4120178A1 New human mitochondrial malate enzyme and DNA encoding it
12/23/1992WO1992022652A1 GABA-A RECEPTOR SUBUNITS (α-2, α-3, α-5, α-6, β-2) AND TRANSFECTED CELLS EXPRESSING THEM
12/23/1992WO1992022644A1 Production of a protein of interest in the milk of a transgenic mammelian
12/23/1992WO1992022640A1 Rb TRANSFERRED CELLS AND METHOD
12/23/1992WO1992022637A1 Media concentrate technology
12/23/1992WO1992022636A1 Method for inducing human myocardial cell proliferation
12/23/1992WO1992022634A1 Production of monoclonal antibodies
12/23/1992WO1992022584A1 Monoclonal antibodies specific for marrow-derived mesenchymal cells
12/23/1992WO1992022323A1 Intercellular adhesion molecule-3 and its binding ligands
12/23/1992WO1992022319A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-β1 BINDING MOLECULES AND USES THEREOF
12/23/1992WO1992016612A3 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component
12/23/1992EP0519889A2 Leydig cell stimulator
12/23/1992EP0519866A1 Novel anti-HIV antibodies